News

Novavax Shares Rise on FDA License Application Approval for Nuvaxovid
The biotechnology company said the FDA approved the biologics license application for Nuvaxovid to prevent Covid-19 in adults ages 65 and up and individuals ages 12 through 64 who have at least one ...
1BNTX, NVAX : Novavax Wins Limited FDA Nod For COVID Shot—Cleared Only For Seniors...
The U.S. Food and Drug Administration has granted limited approval to Novavax Inc.'s COVID-19 vaccine, restricting its use to ...
Devdiscourse16h
Health Crises Unfold: U.S. FDA Approvals and Global Trade Challenges
Mexico halts Brazilian poultry imports after a bird flu outbreak, the U.S. FDA conditionally approves Novavax's COVID vaccine ...
Novavax (NasdaqGS:NVAX) Reports Q1 2025 Financial Turnaround
Novavax (NasdaqGS:NVAX) recently reported a significant financial turnaround for Q1 2025, demonstrating substantial revenue growth and net income improvements. The amending of its collaboration ...
Why Novavax Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Novavax shares jumped 16.6% to $7.84 in the pre-market trading session. Here are some other stocks moving in pre-market trading. Markets expect rate cuts — but your earnings don’t have to suffer. Lock ...
Novavax Inc. stock outperforms competitors despite losses on the day
Shares of Novavax Inc. NVAX shed 2.37% to $6.19 Tuesday, on what proved to be an all-around mixed trading session for the ...